acitretin has been researched along with etretinate in 121 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (35.54) | 18.7374 |
1990's | 59 (48.76) | 18.2507 |
2000's | 13 (10.74) | 29.6817 |
2010's | 6 (4.96) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bohoslawec, O; Chan, KK; DeNoble, J; Gabriel, E; Han, RJ; Machlin, LJ; Pawson, BA; Piermattie, V; Specian, AC; Srisethnil, S; Trown, PW | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Christophersen, J; Danneskiold-Samsoe, P; Geiger, JM; Kragballe, K; Larsen, FG; Laurberg, G; Serup, J; Thomsen, K | 1 |
Bollag, W; Jablonska, S; Marczak, M; Szmurlo, A | 1 |
Bouvy, ML; Cornel, MC; De Jong-Van den Berg, LT; Stricker, BH; Sturkenboom, MC; Wesseling, H | 1 |
Fernandes, D; Klein, J; Koren, G; Pastuszak, A | 1 |
Chou, RC; Huselton, CA; Wiegand, UW; Wyss, R | 2 |
Brandt, R; Claudepierre, P; Meyer, J; Tillement, JP; Urien, S | 1 |
De Bersaques, J; De Leenheer, AP; Kint, AH; Lambert, WE; Meyer, E | 2 |
Fritsch, PO | 1 |
Lowe, N | 1 |
Edelson, RL; Gasparro, FP; Tokura, Y | 1 |
Jabłonska, S; Majewski, S; Makieła, B; Marczak, M; Rudnicka, L; Skiendzielewska, A; Skopinska, M; Szmurło, A | 1 |
Barendregt, M; Cornel, MC; de Jong-van den Berg, LT; de Smet, PA; Herings, RM; Stricker, BH | 1 |
Detmar, M; Imcke, E; Mayer-da Silva, A; Orfanos, CE; Ruszczak, Z | 1 |
Happle, R; Steijlen, PM; Van de Kerkhof, PC; van Dooren-Greebe, RJ | 1 |
Happle, R; Perret, CM; Ruiter, DJ; Schuurmans Stekhoven, JH; Steijlen, PM | 1 |
Bitterling, T; Gollnick, H; Orfanos, CE; Rinck, G | 1 |
De Bersaques, JP; De Leenheer, AP; Kint, AH; Lambert, WE | 1 |
Blouin, RA; McNamara, PJ | 1 |
Halioua, B; Saurat, JH | 1 |
O'Brien, TJ | 1 |
Agnish, ND; Dashman, T; DiNardo, B; Rusin, G; Vane, FM | 1 |
elAttar, TM; Lin, HS | 1 |
De Bersaques, JP; De Leenheer, AP; Kint, A; Lambert, WE | 1 |
Carillet, V; Dubertret, L; Hüppe, G; Mazière, JC; Morlière, P; Santus, R | 2 |
Löfberg, B; Nau, H; Reiners, J; Spielmann, H | 1 |
Berne, B; Rollman, O; Vahlquist, A | 1 |
Ehlert, R; Gollnick, H; Orfanos, CE; Rinck, G | 1 |
Hashimoto, Y; Iizuka, H; Ohkuma, N | 1 |
Pihl-Lundin, I; Rollman, O; Vahlquist, A | 1 |
Coble, BI; Dahlgren, C; Molin, L; Stendahl, O | 1 |
Geiger, JM; Lauharanta, J | 1 |
Oikarinen, A | 1 |
Meffert, H; Sönnichsen, N | 1 |
Bjerke, JR; Geiger, JM | 1 |
Jakobsen, P; Kragballe, K; Larsen, FG; Nielsen-Kudsk, F | 1 |
Bjerke, JR; Falk, ES; Geiger, JM; Gip, L; Hjorth, N; Jansén, CT; Kragballe, K; Lauharanta, J; Mork, NJ; Reunala, T | 1 |
Abita, JP; Balitrand, N; Chomienne, C | 1 |
Kingston, TP; Lowe, NJ; Matt, LH | 1 |
Jakobsen, P; Larsen, CG; Larsen, FG | 1 |
Jakobsen, P; Kragballe, K; Larsen, CG; Larsen, FG; Nielsen-Kudsk, F; Nørgaard, A | 1 |
Vahlquist, A | 1 |
Happle, R; Traupe, H; van de Kerkhof, PC | 1 |
Jakobsen, P; Kragballe, K; Larsen, CG; Larsen, FG; Nielsen-Kudsk, F | 1 |
Czarnetzki, BM; Geiger, JM | 1 |
Alfin-Slater, RB; Ashley, JM; Borok, ME; Lowe, NJ | 1 |
Harms, M; Masouyé, I; Saurat, JH | 1 |
Lazarus, V; Lowe, NJ; Matt, L | 1 |
Bauer, R; Brindley, C; Gollnick, H; Hoting, E; Orfanos, CE; Plewig, G; Wokalek, H | 1 |
Geiger, JM; Lassus, A | 1 |
Amblard, P; Beani, JC; Boulanger, A; Claudy, A; Frenk, E; Geiger, JM; Grosshans, E; Guilhou, JJ; Mérot, Y; Saurat, JH | 1 |
Geiger, JM; Ledo, A; Marrón, JM; Martín, M | 1 |
Thongnopnua, P; Zimmerman, CL | 1 |
Bucheli, F; Wyss, R | 1 |
Kochhar, DM; Kraft, JC; Löfberg, B; Nau, H; Reiners, J | 1 |
Gollnick, H; Orfanos, CE; Stadler, R; Tsambaos, D | 1 |
Gollnick, H; Orfanos, CE | 1 |
Kitano, Y; Nagase, N; Okada, N | 1 |
Band, P; Besner, JG; Leclaire, R; Mailhot, S; Meloche, S | 1 |
Dubertret, L; Lebreton, C; Touraine, R | 1 |
Lauharanta, J; Paravicini, U | 1 |
Bauer, R; Orfanos, CE | 1 |
Hamada, K; Kobayashi, K; Mori, M; Morita, E; Ninomiya, T; Okada, Y | 1 |
Rollman, O; Vahlquist, A | 1 |
Hirone, T; Ishizaki, H; Kaminaga, T; Kaseda, H; Masuda, H | 1 |
Annesley, T; Ellis, C; Giacherio, D; Grekin, R; Wilkerson, K | 1 |
DiGiovanna, JJ; Gantt, G; Gross, EG; McClean, SW; Peck, GL; Ruddel, ME | 1 |
Braun-Falco, O; Hein, R; Krieg, T; Mensing, H; Müller, PK | 1 |
Fujita, J; Yoshida, O | 1 |
Palmskog, G | 1 |
Aoyagi, T; Fukaya, T; Iizuka, H; Kamigaki, K; Kato, N; Miura, Y | 1 |
Decker, MA; Zimmerman, CL | 1 |
Arnold, A; Hirte, H; Kowaleski, B; Tozer, R | 1 |
Cornel, MC; de Jong-Van Den Berg, LT; Stricker, BH; Sturkenboom, MC; van Voorst-Vader, PC; Wesseling, H | 1 |
van de Kerkhof, PC; van Dooren-Greebe, RJ | 1 |
Larsen, FG | 1 |
Baudin, M; Geiger, JM; Saurat, JH | 1 |
Bun, H; de Sousa, G; Geiger, JM; Laugier, JP; Rahmani, R; Surber, C | 1 |
Burke, MD; Omar, G; Ormerod, AD; Shah, IA; Whiting, PH | 1 |
Bermann, D; Maibach, HI; Surber, C; Wilhelm, KP | 1 |
Frappaz, A; Larbre, B; Nicolas, JF; Thivolet, J | 1 |
Berbis, P; Chemila, JF; Hesse, S; Privat, Y | 1 |
Geiger, JM; Saurat, JH | 1 |
Jakobsen, P; Knudsen, J; Kragballe, K; Larsen, FG; Nielsen-Kudsk, F; Weismann, K | 1 |
Bergoend, H; Delaporte, E; Feingold, N; Janin, A; N'guyen-Mailfer, C; Piette, F; Savary, JB; Vasseur, F | 1 |
Almond-Roesler, B; Orfanos, CE | 1 |
Abbott, M; Chan, A; Hanna, M; Keane, RJ | 1 |
De Boo, T; Hangx, NM; Kuijpers, AL; Lemmens, JA; Van de Kerkhof, PC; Van Dooren-Greebe, RJ | 1 |
Atherton, DJ; Harper, JI; Lacour, M; Mehta-Nikhar, B | 1 |
Chou, RC; Dittrich, S; Saulnier, E; Schenk, P; Schmitt-Hoffmann, AH | 1 |
Hönigsmann, H; Maier, H | 2 |
Bleiker, TO; Bourke, JF; Graham-Brown, RA; Hutchinson, PE | 1 |
Goerz, G; Herrmann, G; Jungblut, RM | 1 |
Monga, M | 1 |
Katz, HI | 1 |
Chaidaroglou, A; Degiannis, D; Georgiou, S; Koniavitou, K; Tsambaos, D | 1 |
Chou, RC; Wiegand, UW | 1 |
Katz, HI; Leach, EE; Waalen, J | 1 |
Orfanos, CE | 1 |
Gasser, R; Klemisch, W; Knights, KM | 1 |
Brockhoff, PB; Grønhøj Larsen, F; Hjorter, A; Jakobsen, P; Nielsen-Kudsk, F; Steinkjer, B | 1 |
Barbaud, A; Schmutz, JL; Trechot, P | 1 |
Lebwohl, M; Maryles, S; Rozenblit, M | 1 |
Feldman, S; Koo, J; Lebwohl, M; Menter, A | 1 |
Bouwes Bavinck, JN; De Graaf, YG; Euvrard, S | 1 |
Fraunfelder, FT; Fraunfelder, FW | 1 |
Finlay, AY; Katugampola, RP | 1 |
Johnston, GA; Macbeth, AE | 1 |
Chan, SY; Ho, PC; Liu, X | 1 |
Huh, W; Kim, DW; Kim, HG; Kim, HK; Kim, JW; Kim, MH; Kim, YG; Lee, JH; Lee, SY; Park, HD; Youn, JI | 1 |
Chun, MR; Huh, WS; Kim, DW; Kim, HG; Kim, HK; Kim, JW; Kim, MH; Kim, YG; Lee, JH; Lee, SY; Park, HD; Youn, JI | 1 |
Campo-Paysaa, F; Gutierrez-Mazariegos, J; Schubert, M; Theodosiou, M | 1 |
Kim, CH; Lee, SW; Shin, JY; Shin, SY; Shin, YH | 1 |
Cassano, N; Vena, GA | 1 |
Davis, SA; Feldman, SR; Yentzer, BA | 1 |
24 review(s) available for acitretin and etretinate
Article | Year |
---|---|
Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Biotransformation; Etretinate; Humans; Tretinoin | 1992 |
Retinoids in psoriasis and disorders of keratinization.
Topics: Acitretin; Etretinate; Humans; Ichthyosis; Keratosis; Psoriasis | 1992 |
Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
Topics: Abnormalities, Drug-Induced; Acitretin; Adult; Aged; Bone Diseases; Chemical and Drug Induced Liver Injury; Etretinate; Eye Diseases; Female; Humans; Lipids; Male; Middle Aged; Psoriasis; Risk Factors; Skin Diseases; Tretinoin | 1990 |
Retinoids: an overview of pharmacokinetics and therapeutic value.
Topics: Acitretin; Animals; Etretinate; Humans; Isotretinoin; Retinoids; Tretinoin | 1990 |
Retinoids in disorders of keratinization: their use in adults.
Topics: Acitretin; Adult; Etretinate; Humans; Ichthyosis; Keratoderma, Palmoplantar; Keratosis; Pityriasis; Tretinoin | 1987 |
Systemic retinoid therapy for psoriasis.
Topics: Acitretin; Etretinate; Humans; Isomerism; Isotretinoin; Psoriasis; Tretinoin | 1988 |
Current developments of oral retinoid therapy with three generations of drugs. Non-aromatic, monoaromatic and polyaromatic retinoids (arotinoids).
Topics: Acitretin; Administration, Oral; Benzoates; Eczema; Etretinate; Humans; Isotretinoin; Psoriasis; Retinoids; Skin Diseases; Skin Diseases, Vesiculobullous; Tretinoin | 1985 |
Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience.
Topics: Acitretin; Administration, Oral; Animals; Anti-Inflammatory Agents; Etretinate; Granulocytes; Humans; Isotretinoin; Leukocyte Count; Lymphocytes; Macrophages; Mice; Psoriasis; Skin Diseases; Skin Temperature; Tretinoin | 1983 |
The arotinoids: early clinical experience and discussion of future development.
Topics: Acitretin; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Etretinate; Humans; Morpholines; Retinoids | 1994 |
Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis.
Topics: Absorption; Acitretin; Etretinate; Humans; Methotrexate; Psoriasis; Vitamin A | 1994 |
Teratogenic risk with etretinate and acitretin treatment.
Topics: Abnormalities, Drug-Induced; Acitretin; Adolescent; Adult; Animals; Contraceptives, Oral; Dose-Response Relationship, Drug; Etretinate; Female; Fetal Diseases; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Reproducibility of Results; Risk Factors | 1994 |
Acitretin and etretinate. How and when they should be used.
Topics: Acitretin; Algorithms; Clinical Protocols; Drug Interactions; Drug Therapy, Combination; Etretinate; Humans; Mucous Membrane; PUVA Therapy; Skin; Skin Diseases | 1993 |
[Trans-acitretin is metabolized back to etretinate. Importance for oral retinoid therapy].
Topics: Acitretin; Administration, Oral; Animals; Biotransformation; Drug Monitoring; Esterification; Etretinate; Female; Half-Life; Humans; Keratolytic Agents; Pregnancy; Psoriasis; Treatment Outcome | 1996 |
Oral retinoids and pregnancy.
Topics: Abnormalities, Drug-Induced; Acitretin; Administration, Oral; Etretinate; Female; Humans; Isotretinoin; Keratolytic Agents; Pregnancy | 1996 |
Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities.
Topics: Acitretin; Adult; Age Factors; Drug Administration Schedule; Etretinate; Female; Follow-Up Studies; Humans; Hyperostosis, Diffuse Idiopathic Skeletal; Keratolytic Agents; Male; Middle Aged; Osteoporosis; Prospective Studies; Radiography; Spinal Diseases | 1996 |
Vitamin A and its congeners.
Topics: Abnormalities, Drug-Induced; Acitretin; Etretinate; Female; Humans; Isotretinoin; Pregnancy; Retinoids; Tretinoin; Vitamin A | 1997 |
Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Topics: Acitretin; Administration, Topical; Calcitriol; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Drug Synergism; Drug Therapy, Combination; Etretinate; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Ointments; Phototherapy; Psoriasis; Risk; Safety; Treatment Outcome | 1997 |
Pharmacokinetics of acitretin and etretinate.
Topics: Acitretin; Drug Interactions; Etretinate; Humans; Intestinal Absorption; Keratolytic Agents | 1998 |
Acitretin in psoriasis: an overview of adverse effects.
Topics: Abnormalities, Drug-Induced; Acitretin; Drug Interactions; Etretinate; Eye Diseases; Female; Humans; Hyperlipidemias; Hyperostosis; Keratolytic Agents; Liver; Male; Mucous Membrane; Pancreatitis; Pseudotumor Cerebri; Skin Diseases | 1999 |
Treatment of psoriasis with retinoids: present status.
Topics: Acitretin; Etretinate; Humans; Keratolytic Agents; Psoriasis; Retinoids | 1999 |
Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
Topics: Acitretin; Cyclosporine; Drug Therapy, Combination; Etretinate; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Phototherapy; Psoriasis; Recombinant Fusion Proteins; Treatment Outcome | 2003 |
Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
Topics: Acitretin; Administration, Oral; Administration, Topical; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Chemoprevention; Etretinate; Humans; Organ Transplantation; Precancerous Conditions; Retinoids; Skin Neoplasms | 2004 |
Vitamin A: a multifunctional tool for development.
Topics: Acitretin; Aldehyde Oxidoreductases; Animals; Cell Differentiation; Cell Proliferation; Chickens; Developmental Biology; Embryo, Mammalian; Etretinate; Female; Fetal Development; Fetus; Gene Expression Regulation, Developmental; Humans; Mice; Pregnancy; Signal Transduction; Vitamin A; Vitamin A Deficiency | 2011 |
The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs.
Topics: Acitretin; Administration, Topical; Alcohol Drinking; Chronic Disease; Ethanol; Etretinate; Folic Acid Antagonists; Humans; Keratolytic Agents; Psoriasis; Skin | 2012 |
17 trial(s) available for acitretin and etretinate
Article | Year |
---|---|
A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease.
Topics: Acitretin; Adolescent; Adult; Aged; Darier Disease; Double-Blind Method; Etretinate; Female; Humans; Male; Middle Aged; Tretinoin | 1992 |
A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
Topics: Acitretin; Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Etretinate; Female; Humans; Male; Psoriasis; PUVA Therapy; Random Allocation; Tretinoin | 1989 |
Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
Topics: Acitretin; Adult; Double-Blind Method; Etretinate; Humans; Male; Middle Aged; Psoriasis; Random Allocation; Tretinoin | 1989 |
Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
Topics: Acitretin; Double-Blind Method; Etretinate; Female; Humans; Male; Multicenter Studies as Topic; Psoriasis; Random Allocation; Tretinoin | 1989 |
A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Topics: Acitretin; Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Etretinate; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Psoriasis; Random Allocation; Tretinoin | 1989 |
Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
Topics: Acitretin; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Etretinate; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psoriasis; Random Allocation; Time Factors; Tretinoin | 1987 |
Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
Topics: Acitretin; Adult; Aged; Drug Administration Schedule; Etretinate; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Psoriasis; Random Allocation; Tretinoin | 1987 |
Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
Topics: Acitretin; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Etretinate; Female; Humans; Male; Middle Aged; Psoriasis; Random Allocation; Tretinoin | 1988 |
Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
Topics: Acitretin; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Etretinate; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Random Allocation; Tretinoin | 1988 |
Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis.
Topics: Acitretin; Adult; Clinical Trials as Topic; Double-Blind Method; Etretinate; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Psoriasis; PUVA Therapy; Random Allocation; Remission Induction; Tretinoin | 1988 |
Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
Topics: Acitretin; Adult; Aged; Double-Blind Method; Etretinate; Female; Humans; Male; Middle Aged; Psoriasis; Time Factors; Tretinoin | 1988 |
[Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
Topics: Abnormalities, Drug-Induced; Acitretin; Benzoates; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Etretinate; Humans; Lipids; Long-Term Care; Prognosis; Psoriasis; Retinoids; Risk; Skin; Tretinoin | 1985 |
Etretinate: effect of milk intake on absorption.
Topics: Acitretin; Animals; Darier Disease; Etretinate; Humans; Milk; Psoriasis; Tretinoin; Water | 1984 |
Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment.
Topics: Acitretin; Adipose Tissue; Adolescent; Adult; Body Mass Index; Cohort Studies; Cross-Sectional Studies; Etretinate; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Product Surveillance, Postmarketing; Sensitivity and Specificity; Single-Blind Method; Skin Diseases; Teratogens; Tissue Distribution | 1994 |
An appraisal of acitretin therapy in children with inherited disorders of keratinization.
Topics: Acitretin; Child; Child, Preschool; Drug Administration Schedule; Etretinate; Female; Follow-Up Studies; Humans; Hyperkeratosis, Epidermolytic; Ichthyosis; Ichthyosis, Lamellar; Infant; Keratolytic Agents; Male; Sjogren-Larsson Syndrome | 1996 |
Assessment of acitretin-treated female patients of childbearing age and subsequent risk of teratogenicity.
Topics: Acitretin; Adult; Biotransformation; Ethanol; Etretinate; Female; Humans; Keratolytic Agents; Psoriasis | 2001 |
A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects.
Topics: Acitretin; Adult; Area Under Curve; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Etretinate; Half-Life; Humans; Keratolytic Agents; Male; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2009 |
80 other study(ies) available for acitretin and etretinate
Article | Year |
---|---|
Fluorinated retinoic acids and their analogues. 1. Synthesis and Biological activity of (4-methoxy-2,3,6-trimethylphenyl)nonatetraenoic acid analogues.
Topics: Animals; Mice; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Structure-Activity Relationship; Tretinoin | 1979 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antitumor action of retinoids: inhibition of tumor cell line-induced angiogenesis and prevention of tumors in mice.
Topics: Acitretin; Animals; Etretinate; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Sarcoma, Experimental; Tretinoin; Tumor Cells, Cultured | 1992 |
Therapeutic drug monitoring of retinoids.
Topics: Acitretin; Chromatography, High Pressure Liquid; Drug Monitoring; Etretinate; Female; Humans; Retinoids | 1992 |
A potentially new metabolic pathway: ethyl esterification of acitretin.
Topics: Acitretin; Animals; Chromatography, High Pressure Liquid; Esterification; Etretinate; Humans; In Vitro Techniques; Liver; Male; Mass Spectrometry; Rats | 1992 |
Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes.
Topics: Acitretin; Adult; Blood Proteins; Dialysis; Erythrocyte Membrane; Erythrocytes; Etretinate; Humans; Kinetics; Lipoproteins; Lipoproteins, LDL; Male; Protein Binding | 1992 |
Pharmacokinetics and drug interactions of etretinate and acitretin.
Topics: Acitretin; Adult; Aged; Chromatography, High Pressure Liquid; Drug Interactions; Etretinate; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged | 1992 |
Psoriasis symposum. Retinoids.
Topics: Acitretin; Etretinate; Humans; Psoriasis; Retinoids | 1992 |
Retinoid augmentation of bioactive interleukin-1 production by murine keratinocytes.
Topics: Acitretin; Animals; Cells, Cultured; DNA; Etretinate; Female; Interleukin-1; Isotretinoin; Keratinocytes; Methoxsalen; Mice; Mice, Inbred BALB C; Retinoids; Tretinoin; Triamcinolone Acetonide; Ultraviolet Rays | 1992 |
Acitretin decreases tumor cell-induced angiogenesis.
Topics: Acitretin; Animals; Cell Line; Etretinate; Humans; Keratinocytes; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Tretinoin; Tumor Cells, Cultured | 1991 |
[Acitretin; an example of ad-hoc tracing of users in acute problems with drugs].
Topics: Acitretin; Aged; Carcinogens; Etretinate; Female; Humans; Legislation, Drug; Male; Middle Aged; Netherlands; Pharmacies; Tretinoin | 1991 |
Cultivation of human dermal microvascular endothelial cells in vitro: immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids.
Topics: Acitretin; beta 2-Microglobulin; Cell Division; Cells, Cultured; Child; Child, Preschool; Dose-Response Relationship, Drug; Endothelium, Vascular; Etretinate; Humans; Immunohistochemistry; Infant; Infant, Newborn; Isotretinoin; Lectins; Male; Microscopy, Electron; Retinoids; Time Factors; Tretinoin; Vimentin; von Willebrand Factor | 1991 |
A newly discovered xenobiotic metabolic pathway: ethyl ester formation.
Topics: Acitretin; Animals; Esterification; Ethanol; Etretinate; Humans; Liver; Rats; Tretinoin | 1991 |
Ichthyosis bullosa of Siemens responds well to low-dosage oral retinoids.
Topics: Acitretin; Adult; Drug Administration Schedule; Etretinate; Female; Hand; Humans; Ichthyosiform Erythroderma, Congenital; Leg; Male; Middle Aged; Retinoids; Skin; Tretinoin | 1991 |
Ichthyosis bullosa of Siemens: further delineation of the phenotype.
Topics: Acitretin; Adult; Epidermis; Etretinate; Female; Humans; Ichthyosis; Male; Microscopy, Electron; Middle Aged; Pedigree; Phenotype; Tretinoin | 1990 |
[Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
Topics: Acitretin; Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Etretinate; Female; Humans; Long-Term Care; Male; Middle Aged; Psoriasis; Skin Diseases; Tretinoin | 1990 |
High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
Topics: Acitretin; Chromatography, High Pressure Liquid; Etretinate; Humans; Stereoisomerism; Tretinoin | 1990 |
Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
Topics: Acitretin; Animals; Chromatography, High Pressure Liquid; Etretinate; Female; Rats; Rats, Zucker; Tretinoin | 1990 |
Etretin. A replacement for etretinate.
Topics: Acitretin; Etretinate; Humans; Psoriasis; Tretinoin | 1990 |
Teratogenicity of etretinate during early pregnancy in the rat and its correlation with maternal plasma concentrations of the drug.
Topics: Acitretin; Animals; Dose-Response Relationship, Drug; Etretinate; Female; Fetus; Male; Maternal-Fetal Exchange; Pregnancy; Rats; Rats, Inbred Strains; Teratogens; Tretinoin | 1990 |
In vitro inhibition of prostaglandin biosynthesis in squamous cell carcinoma by retinoids.
Topics: Acitretin; Arachidonic Acid; Arachidonic Acids; Benzoates; Carcinoma, Squamous Cell; Dinoprostone; Dose-Response Relationship, Drug; Etretinate; Humans; Prostaglandin-Endoperoxide Synthases; Retinoids; Tongue Neoplasms; Tretinoin; Tumor Cells, Cultured | 1990 |
Persistent etretinate levels in plasma after changing the therapy to acitretin.
Topics: Acitretin; Aged; Drug Interactions; Etretinate; Female; Humans; Male; Middle Aged; Skin Diseases; Tretinoin | 1990 |
Uptake of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, delivered to cultured human fibroblasts by serum proteins. Lack of evidence for perturbation of LDL catabolism.
Topics: Acitretin; Binding, Competitive; Biological Transport; Cells, Cultured; Etretinate; Fibroblasts; Humans; Kinetics; Lipoproteins, HDL; Lipoproteins, LDL; Protein Binding; Serum Albumin; Tretinoin | 1990 |
In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
Topics: Acitretin; Etretinate; Humans; Kinetics; Lipoproteins, HDL; Lipoproteins, LDL; Molecular Structure; Protein Binding; Serum Albumin; Tretinoin | 1990 |
Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Embryonic and Fetal Development; Etretinate; Female; Infusion Pumps, Implantable; Maternal-Fetal Exchange; Mice; Models, Biological; Pregnancy; Tretinoin | 1990 |
UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
Topics: Acitretin; Administration, Oral; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Radiation; Etretinate; Female; In Vitro Techniques; Isomerism; Isotretinoin; Mice; Mice, Hairless; Retinoids; Skin; Tretinoin; Ultraviolet Rays | 1990 |
Effects of retinoids on DNA synthesis of pig epidermis: its relation to epidermal beta-adrenergic adenylate cyclase response and to epidermal superoxide dismutase activity.
Topics: Acitretin; Adenylyl Cyclases; Animals; Cell Division; DNA; Epidermis; Etretinate; Keratinocytes; Retinoids; Superoxide Dismutase; Swine; Thymidine; Tretinoin; Vitamin A | 1990 |
Tissue distribution of aromatic retinoid (etretinate) in three autopsy cases: drug accumulation in adrenals and fat.
Topics: Acitretin; Adipose Tissue; Adrenal Glands; Adult; Aged; Aged, 80 and over; Etretinate; Humans; Ichthyosis; Male; Psoriasis; Tissue Distribution; Tretinoin | 1986 |
Neutrophil function in psoriasis: effects of retinoids.
Topics: Acitretin; Dermatologic Agents; Etretinate; Female; Humans; In Vitro Techniques; Isotretinoin; Luminescent Measurements; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phagocytosis; Psoriasis; Retinoids; Tetradecanoylphorbol Acetate; Tretinoin | 1987 |
Comparison of the effects of retinoids and glucocorticosteroid on protein and type IV collagen synthesis in HT-1080 (human basement membrane forming fibrosarcoma) cells.
Topics: Acitretin; Collagen; Dexamethasone; Electrophoresis, Starch Gel; Etretinate; Fibronectins; Fibrosarcoma; Isotretinoin; Retinoids; Tretinoin; Tumor Cells, Cultured; Vitamin A | 1989 |
Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
Topics: Acitretin; Aged; Etretinate; Female; Half-Life; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Psoriasis; Tretinoin | 1989 |
Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in-vitro differentiation of leukemic cells.
Topics: Acitretin; Cell Differentiation; Cell Line; Etretinate; Humans; Leukemia, Myeloid, Acute; Stereoisomerism; Structure-Activity Relationship; Tretinoin | 1986 |
Simultaneous determination of the aromatic retinoids etretin and etretinate and their main metabolites by reversed-phase liquid chromatography.
Topics: Acitretin; Chromatography, High Pressure Liquid; Etretinate; Humans; Isomerism; Kinetics; Psoriasis; Tretinoin | 1987 |
Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients.
Topics: Acitretin; Etretinate; Humans; Kidney Failure, Chronic; Kidney Function Tests; Psoriasis; Tretinoin | 1987 |
Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
Topics: Acitretin; Adult; Aged; Etretinate; Female; Half-Life; Humans; Male; Middle Aged; Psoriasis; Tretinoin | 1988 |
Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies.
Topics: Acitretin; Adolescent; Adult; Child; Child, Preschool; Etretinate; Female; Humans; Male; Middle Aged; Psoriasis; Skin; Tretinoin | 1988 |
Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.
Topics: Acitretin; Adult; Aged; Cholesterol; Cholesterol, HDL; Etretinate; Female; Fish Oils; Humans; Hyperlipoproteinemias; Male; Middle Aged; Prothrombin Time; Psoriasis; Tretinoin; Triglycerides | 1988 |
["Crocodile baby", a non-fatal form of malignant keratoma?].
Topics: Acitretin; Adult; Dermatitis, Exfoliative; Diagnosis, Differential; Etretinate; Female; Humans; Ichthyosis; Keratosis; Optic Atrophy; Pedigree; Tretinoin | 1988 |
Simultaneous microassay for etretinate and its active metabolite, etretin, by reversed-phase high-performance liquid chromatography.
Topics: Acitretin; Animals; Chromatography, High Pressure Liquid; Diterpenes; Etretinate; Rats; Retinyl Esters; Spectrophotometry, Ultraviolet; Tretinoin; Vitamin A | 1988 |
Quantitative analysis of retinoids in biological fluids by high-performance liquid chromatography using column switching. II. Simultaneous determination of etretinate, acitretin and 13-cis-acitretin in plasma.
Topics: Acitretin; Animals; Chromatography, High Pressure Liquid; Etretinate; Humans; Indicators and Reagents; Mice; Rats; Retinoids; Solutions; Temperature; Tretinoin | 1988 |
Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
Topics: Abnormalities, Drug-Induced; Acitretin; Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Etretinate; Female; Maternal-Fetal Exchange; Mice; Mice, Inbred Strains; Molecular Structure; Placenta; Pregnancy; Tretinoin | 1988 |
Metabolism of an aromatic retinoid Ro 10-9359 by cultured human epidermal keratinocytes.
Topics: Acitretin; Animals; Cells, Cultured; Child; Epidermis; Etretinate; Female; Fibroblasts; HeLa Cells; Humans; Keratins; Liver; Mice; Tretinoin | 1982 |
High-performance liquid chromatography of Ro 10-9359 (tigason) and its metabolite Ro 10-1670 in human plasma.
Topics: Acitretin; Chromatography, High Pressure Liquid; Diterpenes; Etretinate; Humans; Retinyl Esters; Tretinoin; Vitamin A | 1982 |
Inhibition of neutrophil migration by etretinate and its main metabolite.
Topics: Acitretin; Adult; Blood Bactericidal Activity; Cell Movement; Dose-Response Relationship, Drug; Etretinate; Humans; Male; Neutrophils; Phagocytosis; Skin; Tretinoin | 1982 |
Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.
Topics: Acitretin; Adult; Biological Availability; Blister; Etretinate; Exudates and Transudates; Female; Half-Life; Humans; Male; Middle Aged; Psoriasis; Time Factors; Tretinoin | 1982 |
[Antitumor effects of aromatic retinoids (Ro 10-1670, Ro 10-9359) on the chemically-induced epithelial tumors].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acitretin; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cricetinae; Etretinate; Mesocricetus; Mice; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Tretinoin | 1982 |
Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
Topics: Acitretin; Adipose Tissue; Adolescent; Adult; Aged; Biological Availability; Child; Etretinate; Female; Humans; Male; Middle Aged; Skin; Skin Diseases; Tretinoin | 1983 |
Serum levels of Etretinate (Ro 10-9359) and its metabolite (Ro 10-1670).
Topics: Acitretin; Adolescent; Adult; Etretinate; Female; Humans; Keratoderma, Palmoplantar; Male; Middle Aged; Pityriasis; Psoriasis; Tretinoin | 1983 |
Analysis of retinoids by high-performance liquid chromatography using programmed gradient separation.
Topics: Acitretin; Chromatography, High Pressure Liquid; Diterpenes; Etretinate; Humans; Retinoids; Retinyl Esters; Tretinoin; Vitamin A | 1984 |
Effect of vitamin A and its derivatives on collagen production and chemotactic response of fibroblasts.
Topics: Acitretin; Cell Division; Cells, Cultured; Chemotaxis; Collagen; Etretinate; Fibroblasts; Humans; Isotretinoin; Protein Biosynthesis; Tretinoin; Vitamin A | 1984 |
[Inhibitory effects of aromatic retinoic acid analog, administered alone or in combination with mitomycin C, on the in vitro growth of rat bladder carcinoma cells].
Topics: Acitretin; Animals; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Etretinate; Mitomycin; Mitomycins; Rats; Tretinoin; Urinary Bladder Neoplasms | 1984 |
Determination of plasma levels of two aromatic retinoic acid analogues with antipsoriatic activity by high-performance liquid chromatography.
Topics: Acitretin; Chromatography, High Pressure Liquid; Etretinate; Humans; Kinetics; Reference Standards; Spectrophotometry, Ultraviolet; Tretinoin | 1980 |
Retinoid stimulates epidermal outgrowth of pig skin explants.
Topics: Acitretin; Animals; Culture Techniques; Epidermal Cells; Epidermis; Etretinate; Mitosis; Swine; Tretinoin | 1981 |
Simultaneous determination of etretinate, acitretin and their metabolites in perfusate, perfusate plasma, bile or hepatic tissue with reversed-phase high-performance liquid chromatography.
Topics: Acitretin; Animals; Bile; Chromatography, High Pressure Liquid; Etretinate; Liver; Rats; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1995 |
Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris.
Topics: Acetabulum; Acitretin; Adolescent; Adult; Azathioprine; Child; Etretinate; Exostoses; Femur Neck; Follow-Up Studies; Humans; Hyperostosis; Male; Methotrexate; Pityriasis Rubra Pilaris; Retinoids; Tretinoin | 1995 |
Skin, adipose tissue and plasma levels of acitretin with rare occurrence of esterified acitretin during long-term treatment.
Topics: Acitretin; Adipose Tissue; Adult; Aged; Chromatography, High Pressure Liquid; Esterification; Etretinate; Female; Humans; Keratosis; Male; Middle Aged; Psoriasis; Skin; Time Factors | 1993 |
Acitretin biotransformation into etretinate: role of ethanol on in vitro hepatic metabolism.
Topics: Acitretin; Animals; Biotransformation; Cells, Cultured; Dogs; Esterification; Ethanol; Etretinate; Humans; Liver; Macaca fascicularis; Male; Rats; Rats, Wistar | 1994 |
The effects of retinoids and terbinafine on the human hepatic microsomal metabolism of cyclosporin.
Topics: Acitretin; Aged; Antifungal Agents; Cyclosporine; Drug Therapy, Combination; Etretinate; Female; Humans; In Vitro Techniques; Isotretinoin; Male; Microsomes, Liver; Middle Aged; Naphthalenes; Psoriasis; Retinoids; Terbinafine | 1993 |
In vivo skin penetration of acitretin in volunteers using three sampling techniques.
Topics: Acitretin; Administration, Topical; Adult; Blood Specimen Collection; Etretinate; Humans; Male; Skin Absorption | 1993 |
[Cyclosporine and Darier's disease].
Topics: Acitretin; Cyclosporine; Darier Disease; Etretinate; Humans; Male; Middle Aged; Treatment Failure | 1993 |
Psoriasis and birdshot chorioretinopathy: response to aromatic retinoids.
Topics: Acitretin; Chorioretinitis; Drug Therapy, Combination; Etretinate; Humans; Male; Middle Aged; Psoriasis; Vitiligo | 1993 |
Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
Topics: Acitretin; Adult; Alcohol Drinking; Ethanol; Etretinate; Female; Half-Life; Humans; Male; Middle Aged; Osmolar Concentration; Psoriasis; Time Factors | 1993 |
Keratoderma with scleroatrophy of the extremities or sclerotylosis (Huriez syndrome): a reappraisal.
Topics: Acitretin; Adult; Carcinoma, Squamous Cell; DNA Repair; Drug Therapy, Combination; Etretinate; Female; Genetic Linkage; Humans; Keratoderma, Palmoplantar; Keratolytic Agents; Male; Middle Aged; Pedigree; Skin Neoplasms | 1995 |
Mechanistic studies on the ethyl-esterification of acitretin by human liver preparations in vitro.
Topics: Acitretin; Adenosine Triphosphate; Coenzyme A; Esterification; Ethanol; Etretinate; Humans; Keratolytic Agents; Liver; Microsomes, Liver; NADP | 1995 |
Concentration of etretinate in plasma and subcutaneous fat after long-term acitretin.
Topics: Acitretin; Adipose Tissue; Adult; Etretinate; Female; Humans; Keratolytic Agents | 1996 |
Etretinate may work where acitretin fails.
Topics: Acitretin; Adolescent; Adult; Aged; Aged, 80 and over; Darier Disease; Etretinate; Female; Hand Dermatoses; Humans; Keratoderma, Palmoplantar; Keratolytic Agents; Male; Psoriasis; Skin Diseases; Treatment Failure | 1997 |
Skeletal changes after long-term therapy with synthetic retinoids.
Topics: Acitretin; Adult; Aged; Bone and Bones; Etretinate; Female; Humans; Keratolytic Agents; Male; Time Factors | 1997 |
In vitro effects of retinoids on mitogen-induced peripheral blood leucocyte responses.
Topics: Acitretin; Adult; Carcinogens; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Etretinate; Humans; Immunosuppressive Agents; Isotretinoin; Keratolytic Agents; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lymphocyte Activation; Lymphocytes; Middle Aged; Mitogens; Phytohemagglutinins; Polyenes; Retinoids; Sirolimus; Tetradecanoylphorbol Acetate | 1998 |
In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate.
Topics: Acetaldehyde; Acetates; Acitretin; Acyl Coenzyme A; Coenzyme A Ligases; Esterification; Ethanol; Etretinate; Humans; In Vitro Techniques; Microsomes, Liver; Repressor Proteins; Saccharomyces cerevisiae Proteins | 2000 |
Acitretin is converted to etretinate only during concomitant alcohol intake.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Ethanol; Etretinate; Female; Humans; Keratolytic Agents; Logistic Models; Male; Middle Aged; Risk Factors; Skin Diseases | 2000 |
[Treatment with acitretin and alcohol drinking: a high risk combination].
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Biotransformation; Dose-Response Relationship, Drug; Drug Interactions; Etretinate; Female; Humans; Infant, Newborn; Male; Metabolic Clearance Rate; Middle Aged; Pregnancy; Risk Factors | 2001 |
Case studies in severe psoriasis: A clinical strategy.
Topics: Acitretin; Adolescent; Adult; Aged; Algorithms; Dermatologic Agents; Drug Therapy, Combination; Etretinate; Female; Health Surveys; Humans; Keratolytic Agents; Male; Methotrexate; Middle Aged; Psoriasis; Recombinant Fusion Proteins; Severity of Illness Index; Treatment Outcome; Ultraviolet Therapy | 2003 |
Evidence for a probable causal relationship between tretinoin, acitretin, and etretinate and intracranial hypertension.
Topics: Acitretin; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Child; Etretinate; Female; Humans; Intracranial Hypertension; Keratolytic Agents; Male; Registries; Tretinoin; United States; United States Food and Drug Administration; Vision Disorders; World Health Organization | 2004 |
Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
Topics: Acitretin; Administration, Oral; Adolescent; Adult; Child; Child, Preschool; Drug Administration Schedule; Etretinate; Female; Follow-Up Studies; Humans; Hyperostosis; Keratolytic Agents; Keratosis; Middle Aged; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Radiography; Retinoids; Retrospective Studies; Spinal Diseases | 2006 |
Twenty-one years of oral retinoid therapy in siblings with nonbullous ichthyosiform erythroderma.
Topics: Acitretin; Adult; Etretinate; Humans; Ichthyosiform Erythroderma, Congenital; Keratolytic Agents; Male; Siblings; Treatment Outcome | 2008 |
Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
Topics: Acitretin; Alitretinoin; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Culture Media, Conditioned; Etretinate; Fibroblasts; Fluorouracil; Humans; In Vitro Techniques; Isotretinoin; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Retinoids; Tretinoin | 2008 |
Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
Topics: Acitretin; Adolescent; Adult; Aged; Biological Products; Blood Donors; Blood Transfusion; Chromatography, High Pressure Liquid; Drug Contamination; Etretinate; Female; Half-Life; Humans; Male; Middle Aged; Psoriasis; Teratogens; Transfusion Reaction | 2008 |
Blood donors on teratogenic drugs and donor deferral periods in a clinical situation.
Topics: Acitretin; Adult; Blood Donors; Etretinate; Female; Finasteride; Humans; Teratogens; Transfusion Reaction; Young Adult | 2012 |
Acitretin prescribing patterns in women of childbearing potential.
Topics: Acitretin; Adult; Age Factors; Aged; Databases, Factual; Etretinate; Female; Health Care Surveys; Humans; Keratolytic Agents; Male; Middle Aged; Practice Patterns, Physicians'; Psoriasis; Severity of Illness Index; United States | 2013 |